FI945854A0 - 6,7-dihydro-3-(2-nitrofenyyli)bentsisoksatsol-4(5H)-oneja ja menetelmä niiden valmistamiseksi - Google Patents

6,7-dihydro-3-(2-nitrofenyyli)bentsisoksatsol-4(5H)-oneja ja menetelmä niiden valmistamiseksi

Info

Publication number
FI945854A0
FI945854A0 FI945854A FI945854A FI945854A0 FI 945854 A0 FI945854 A0 FI 945854A0 FI 945854 A FI945854 A FI 945854A FI 945854 A FI945854 A FI 945854A FI 945854 A0 FI945854 A0 FI 945854A0
Authority
FI
Finland
Prior art keywords
hydrogen
loweralkyl
preparation
benzisoxazole
nitrophenyl
Prior art date
Application number
FI945854A
Other languages
English (en)
Swedish (sv)
Other versions
FI97056C (fi
FI945854A (fi
FI97056B (fi
Inventor
Gregory Michael Shutske
Kevin James Kapples
John Dick Tomer
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI945854A publication Critical patent/FI945854A/fi
Publication of FI945854A0 publication Critical patent/FI945854A0/fi
Application granted granted Critical
Publication of FI97056B publication Critical patent/FI97056B/fi
Publication of FI97056C publication Critical patent/FI97056C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/12Organo silicon halides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI945854A 1991-02-13 1994-12-13 6,7-dihydro-3-(2-nitrofenyyli)bentsisoksatsol-4(5H)-oneja ja menetelmä niiden valmistamiseksi FI97056C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/654,691 US5210087A (en) 1991-02-13 1991-02-13 9-aminotetrahydroacridines and related compounds
US65469191 1991-02-13

Publications (4)

Publication Number Publication Date
FI945854A FI945854A (fi) 1994-12-13
FI945854A0 true FI945854A0 (fi) 1994-12-13
FI97056B FI97056B (fi) 1996-06-28
FI97056C FI97056C (fi) 1996-10-10

Family

ID=24625869

Family Applications (2)

Application Number Title Priority Date Filing Date
FI920566A FI96308C (fi) 1991-02-13 1992-02-11 Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi
FI945854A FI97056C (fi) 1991-02-13 1994-12-13 6,7-dihydro-3-(2-nitrofenyyli)bentsisoksatsol-4(5H)-oneja ja menetelmä niiden valmistamiseksi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI920566A FI96308C (fi) 1991-02-13 1992-02-11 Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi

Country Status (25)

Country Link
US (3) US5210087A (fi)
EP (1) EP0499231B1 (fi)
JP (1) JPH07121915B2 (fi)
KR (1) KR100223132B1 (fi)
AT (1) ATE153331T1 (fi)
AU (1) AU664165B2 (fi)
BR (1) BR9200475A (fi)
CA (1) CA2061084A1 (fi)
CZ (1) CZ281927B6 (fi)
DE (1) DE69219801T2 (fi)
DK (1) DK0499231T3 (fi)
ES (1) ES2102417T3 (fi)
FI (2) FI96308C (fi)
GR (1) GR3024310T3 (fi)
HU (1) HU219451B (fi)
IE (1) IE920459A1 (fi)
IL (3) IL117795A (fi)
MX (1) MX9200607A (fi)
NO (1) NO177933C (fi)
NZ (3) NZ260694A (fi)
PL (6) PL168153B1 (fi)
RO (1) RO112354B1 (fi)
RU (1) RU2083564C1 (fi)
TW (1) TW221426B (fi)
ZA (1) ZA921004B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210087A (en) * 1991-02-13 1993-05-11 Hoechst-Roussel Pharmaceuticals Inc. 9-aminotetrahydroacridines and related compounds
ES2059263B1 (es) * 1992-10-27 1995-10-01 Vita Invest Sa Procedimiento para la obtencion del (+)-9-amino-1,2,3,4-tetrahidroacridin-1-ol.
US5434170A (en) * 1993-12-23 1995-07-18 Andrulis Pharmaceuticals Corp. Method for treating neurocognitive disorders
ES2144353B1 (es) * 1997-12-26 2001-01-01 Consejo Superior Investigacion Nuevos analogos de tacrina: potenciales agentes neuroprotectores para las enfermedades de alzheimer y parkinson. su procedimiento de obtencion.
EP1484325B1 (en) * 2002-03-08 2014-06-18 Japan Science and Technology Agency Isoxazole derivatives and process for producing the same
RU2616247C1 (ru) * 2016-03-28 2017-04-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинский государственный университет имени Коста Левановича Хетагурова" (СОГУ) Твердая лекарственная форма, обладающая холинопозитивным действием, на основе 9-бутиламино-3,3-диметил-1,2,4-тригидроакридина

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232945A (en) * 1962-08-13 1966-02-01 S E Massengill Company 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines
EP0179383B1 (en) * 1984-10-25 1991-05-29 Hoechst-Roussel Pharmaceuticals Incorporated 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US4631286A (en) * 1984-10-25 1986-12-23 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
WO1989002739A1 (en) * 1987-10-05 1989-04-06 Pfizer Inc. 4-aminopyridine derivatives
GB8827704D0 (en) * 1988-11-28 1988-12-29 Fujisawa Pharmaceutical Co New acridine derivatives & processes for their production
US5441727A (en) * 1989-06-21 1995-08-15 The Procter & Gamble Company Diketone deodorant composition and method of deodorization
US5053513A (en) * 1990-03-29 1991-10-01 Hoechst-Roussel Pharmaceuticals Incorporated Method of reducing a carbonyl containing acridine
US5210087A (en) * 1991-02-13 1993-05-11 Hoechst-Roussel Pharmaceuticals Inc. 9-aminotetrahydroacridines and related compounds
GB2264707A (en) * 1991-06-18 1993-09-08 Roger Michael Marchbanks Acridine derivatives for treating alzheimer's disease

Also Published As

Publication number Publication date
IE920459A1 (en) 1992-08-12
US5502203A (en) 1996-03-26
FI96308C (fi) 1996-06-10
FI920566A0 (fi) 1992-02-11
RO112354B1 (ro) 1997-08-29
PL166939B1 (pl) 1995-07-31
PL168153B1 (pl) 1996-01-31
IL100921A (en) 1998-12-27
EP0499231B1 (en) 1997-05-21
PL296319A1 (en) 1993-07-12
PL293443A1 (en) 1993-03-08
NZ260694A (en) 1996-02-27
NO920547L (no) 1992-08-14
CZ281927B6 (cs) 1997-04-16
NO177933B (no) 1995-09-11
RU2083564C1 (ru) 1997-07-10
AU1090392A (en) 1992-08-20
DE69219801T2 (de) 1997-11-27
CA2061084A1 (en) 1992-08-14
IL117795A (en) 1998-01-04
HU9200423D0 (en) 1992-04-28
TW221426B (fi) 1994-03-01
JPH07121915B2 (ja) 1995-12-25
NZ241586A (en) 1996-02-27
HUT67032A (en) 1995-01-30
CS42692A3 (en) 1992-09-16
DK0499231T3 (da) 1997-12-01
NO177933C (no) 1995-12-20
FI97056C (fi) 1996-10-10
KR100223132B1 (ko) 1999-10-15
IL117795A0 (en) 1996-08-04
PL168862B1 (pl) 1996-04-30
PL296320A1 (en) 1993-07-12
FI945854A (fi) 1994-12-13
US5382594A (en) 1995-01-17
JPH04312578A (ja) 1992-11-04
MX9200607A (es) 1992-11-30
FI96308B (fi) 1996-02-29
EP0499231A1 (en) 1992-08-19
PL169095B1 (pl) 1996-05-31
FI920566A (fi) 1992-08-14
ATE153331T1 (de) 1997-06-15
DE69219801D1 (de) 1997-06-26
HU219451B (hu) 2001-04-28
ES2102417T3 (es) 1997-08-01
FI97056B (fi) 1996-06-28
AU664165B2 (en) 1995-11-09
PL168906B1 (pl) 1996-05-31
ZA921004B (en) 1992-10-28
US5210087A (en) 1993-05-11
NO920547D0 (no) 1992-02-12
NZ270647A (en) 1996-02-27
KR920016426A (ko) 1992-09-24
BR9200475A (pt) 1992-10-20
PL168861B1 (pl) 1996-04-30
GR3024310T3 (en) 1997-10-31

Similar Documents

Publication Publication Date Title
FI945854A0 (fi) 6,7-dihydro-3-(2-nitrofenyyli)bentsisoksatsol-4(5H)-oneja ja menetelmä niiden valmistamiseksi
ZA898498B (en) 1,2,3,4-tetrahydro-1,9-acridinediamines,a process for their preparation and their use as medicaments
DK592589D0 (da) Kondenserede heterocycliske derivater af 1,2,3,4-tetrahydroacridin, deres fremstilling og anvendelse
IL94664A0 (en) 4,5,5a,6-tetrahydro-3h-isoxazolo(5,4,3-ki)acridine derivatives,process for their preparation and their use as medicaments
NO179583C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-(pyridinylalkyl)-1H-indoler

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: HOECHST MARION ROUSSEL, INC.